

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | heme biosynthetic process (GO:0006783) | 9.03522798 |
| 2 | urate metabolic process (GO:0046415) | 7.84195049 |
| 3 | porphyrin-containing compound biosynthetic process (GO:0006779) | 7.76419437 |
| 4 | drug transmembrane transport (GO:0006855) | 7.63755868 |
| 5 | heme metabolic process (GO:0042168) | 7.54564251 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.15096861 |
| 7 | tetrapyrrole biosynthetic process (GO:0033014) | 7.08738910 |
| 8 | drug transport (GO:0015893) | 6.51494156 |
| 9 | porphyrin-containing compound metabolic process (GO:0006778) | 6.38711259 |
| 10 | organic cation transport (GO:0015695) | 6.21591471 |
| 11 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.75944903 |
| 12 | lysine metabolic process (GO:0006553) | 5.75784296 |
| 13 | lysine catabolic process (GO:0006554) | 5.75784296 |
| 14 | glycosphingolipid catabolic process (GO:0046479) | 5.47260232 |
| 15 | cysteine metabolic process (GO:0006534) | 5.33939585 |
| 16 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 5.25544859 |
| 17 | positive regulation of heat generation (GO:0031652) | 5.00430710 |
| 18 | tetrapyrrole metabolic process (GO:0033013) | 4.95010602 |
| 19 | glycolipid catabolic process (GO:0019377) | 4.89907273 |
| 20 | regulation of fever generation (GO:0031620) | 4.89771088 |
| 21 | regulation of cholesterol storage (GO:0010885) | 4.87020270 |
| 22 | response to folic acid (GO:0051593) | 4.71537454 |
| 23 | phosphate ion transport (GO:0006817) | 4.55106355 |
| 24 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.54874732 |
| 25 | hydrogen peroxide catabolic process (GO:0042744) | 4.49838789 |
| 26 | tryptophan catabolic process (GO:0006569) | 4.49627572 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.49627572 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.49627572 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 4.47706573 |
| 30 | protein-cofactor linkage (GO:0018065) | 4.47674477 |
| 31 | pigment biosynthetic process (GO:0046148) | 4.46820809 |
| 32 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.42895421 |
| 33 | regulation of chronic inflammatory response (GO:0002676) | 4.39671732 |
| 34 | renal absorption (GO:0070293) | 4.39317182 |
| 35 | response to peptidoglycan (GO:0032494) | 4.38484953 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 4.35992951 |
| 37 | amino sugar catabolic process (GO:0046348) | 4.32153223 |
| 38 | hemoglobin metabolic process (GO:0020027) | 4.29337324 |
| 39 | pigment metabolic process (GO:0042440) | 4.28741086 |
| 40 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.28408903 |
| 41 | glyoxylate metabolic process (GO:0046487) | 4.28072326 |
| 42 | tryptophan metabolic process (GO:0006568) | 4.26978563 |
| 43 | myeloid dendritic cell differentiation (GO:0043011) | 4.25929400 |
| 44 | ceramide catabolic process (GO:0046514) | 4.24969242 |
| 45 | erythrocyte maturation (GO:0043249) | 4.24609218 |
| 46 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.15159459 |
| 47 | exogenous drug catabolic process (GO:0042738) | 4.14707786 |
| 48 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.12202907 |
| 49 | fructose metabolic process (GO:0006000) | 4.12170399 |
| 50 | drug catabolic process (GO:0042737) | 4.11782233 |
| 51 | vitamin D metabolic process (GO:0042359) | 4.11295903 |
| 52 | regulation of mononuclear cell migration (GO:0071675) | 4.10634727 |
| 53 | aromatic amino acid family catabolic process (GO:0009074) | 4.03926877 |
| 54 | excretion (GO:0007588) | 3.99375991 |
| 55 | response to lead ion (GO:0010288) | 3.98157710 |
| 56 | response to mercury ion (GO:0046689) | 3.97117297 |
| 57 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.96325888 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.94095367 |
| 59 | branched-chain amino acid metabolic process (GO:0009081) | 3.93620759 |
| 60 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.92202458 |
| 61 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.90792285 |
| 62 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.90775602 |
| 63 | monocyte chemotaxis (GO:0002548) | 3.88092121 |
| 64 | regulation of podosome assembly (GO:0071801) | 3.87847777 |
| 65 | quaternary ammonium group transport (GO:0015697) | 3.84004752 |
| 66 | phosphate ion transmembrane transport (GO:0035435) | 3.78674780 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.78228077 |
| 68 | osteoclast differentiation (GO:0030316) | 3.77606578 |
| 69 | toxin transport (GO:1901998) | 3.77011756 |
| 70 | one-carbon compound transport (GO:0019755) | 3.74921066 |
| 71 | eosinophil chemotaxis (GO:0048245) | 3.74420810 |
| 72 | membrane lipid catabolic process (GO:0046466) | 3.72912907 |
| 73 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.71915284 |
| 74 | heme transport (GO:0015886) | 3.71556983 |
| 75 | sphingolipid catabolic process (GO:0030149) | 3.71434580 |
| 76 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.70999515 |
| 77 | phosphate ion homeostasis (GO:0055062) | 3.69698624 |
| 78 | trivalent inorganic anion homeostasis (GO:0072506) | 3.69698624 |
| 79 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.69013000 |
| 80 | regulation of heat generation (GO:0031650) | 3.65590160 |
| 81 | positive regulation of lipid storage (GO:0010884) | 3.63574902 |
| 82 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.63145668 |
| 83 | branched-chain amino acid catabolic process (GO:0009083) | 3.61074257 |
| 84 | adhesion of symbiont to host cell (GO:0044650) | 3.60487654 |
| 85 | virion attachment to host cell (GO:0019062) | 3.60487654 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 3.59710276 |
| 87 | homocysteine metabolic process (GO:0050667) | 3.59410048 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 3.56704173 |
| 89 | amine catabolic process (GO:0009310) | 3.56704173 |
| 90 | regulation of chemokine biosynthetic process (GO:0045073) | 3.54841107 |
| 91 | amino-acid betaine metabolic process (GO:0006577) | 3.54155270 |
| 92 | erythrocyte development (GO:0048821) | 3.54018264 |
| 93 | negative regulation of lipid storage (GO:0010888) | 3.52042810 |
| 94 | serine family amino acid metabolic process (GO:0009069) | 3.48771414 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.45757723 |
| 96 | L-phenylalanine catabolic process (GO:0006559) | 3.45757723 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.45603586 |
| 98 | oligosaccharide catabolic process (GO:0009313) | 3.45361793 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.44417168 |
| 100 | L-phenylalanine metabolic process (GO:0006558) | 3.44417168 |
| 101 | glutathione biosynthetic process (GO:0006750) | 3.42570089 |
| 102 | regulation of interferon-alpha production (GO:0032647) | 3.42232287 |
| 103 | aldehyde catabolic process (GO:0046185) | 3.41933862 |
| 104 | proline metabolic process (GO:0006560) | 3.41386763 |
| 105 | metanephric nephron tubule development (GO:0072234) | 3.39632799 |
| 106 | metanephric tubule development (GO:0072170) | 3.39632799 |
| 107 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.39106642 |
| 108 | glycoside metabolic process (GO:0016137) | 3.37194341 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 3.36677696 |
| 110 | activation of MAPKKK activity (GO:0000185) | 3.35819600 |
| 111 | indolalkylamine metabolic process (GO:0006586) | 3.34046263 |
| 112 | serine family amino acid catabolic process (GO:0009071) | 3.33962889 |
| 113 | carnitine metabolic process (GO:0009437) | 3.31937220 |
| 114 | immunoglobulin mediated immune response (GO:0016064) | 3.28691166 |
| 115 | cellular response to type I interferon (GO:0071357) | 3.27596027 |
| 116 | type I interferon signaling pathway (GO:0060337) | 3.27596027 |
| 117 | response to thyroid hormone (GO:0097066) | 3.26752937 |
| 118 | eosinophil migration (GO:0072677) | 3.25687356 |
| 119 | regulation of monocyte differentiation (GO:0045655) | 3.24980758 |
| 120 | germinal center formation (GO:0002467) | 3.22615636 |
| 121 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.21212482 |
| 122 | positive regulation of cholesterol efflux (GO:0010875) | 3.21129314 |
| 123 | response to type I interferon (GO:0034340) | 3.20580180 |
| 124 | kynurenine metabolic process (GO:0070189) | 3.19330944 |
| 125 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.17168597 |
| 126 | polyol transport (GO:0015791) | 3.13845238 |
| 127 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.12971633 |
| 128 | hydrogen peroxide metabolic process (GO:0042743) | 3.12582206 |
| 129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.12579327 |
| 130 | regulation of lipid storage (GO:0010883) | 3.11469741 |
| 131 | adhesion of symbiont to host (GO:0044406) | 3.11296098 |
| 132 | dopamine transport (GO:0015872) | 3.08287346 |
| 133 | aspartate family amino acid catabolic process (GO:0009068) | 3.08149011 |
| 134 | positive regulation of acute inflammatory response (GO:0002675) | 3.06881641 |
| 135 | response to muramyl dipeptide (GO:0032495) | 3.06512710 |
| 136 | negative regulation of amino acid transport (GO:0051956) | 3.05521242 |
| 137 | macrophage activation involved in immune response (GO:0002281) | 3.05096056 |
| 138 | metallo-sulfur cluster assembly (GO:0031163) | 3.04849455 |
| 139 | iron-sulfur cluster assembly (GO:0016226) | 3.04849455 |
| 140 | valine metabolic process (GO:0006573) | 3.04266898 |
| 141 | T-helper 1 type immune response (GO:0042088) | 3.03331748 |
| 142 | metanephric nephron epithelium development (GO:0072243) | 3.02390359 |
| 143 | neutrophil activation involved in immune response (GO:0002283) | 3.01256143 |
| 144 | removal of superoxide radicals (GO:0019430) | 3.00698381 |
| 145 | cellular response to superoxide (GO:0071451) | 3.00698381 |
| 146 | cellular response to oxygen radical (GO:0071450) | 3.00698381 |
| 147 | cofactor biosynthetic process (GO:0051188) | 3.00584923 |
| 148 | glutathione derivative metabolic process (GO:1901685) | 2.99290260 |
| 149 | glutathione derivative biosynthetic process (GO:1901687) | 2.99290260 |
| 150 | glutathione metabolic process (GO:0006749) | 2.98750069 |
| 151 | NAD biosynthetic process (GO:0009435) | 2.98498202 |
| 152 | dendritic cell differentiation (GO:0097028) | 2.97711244 |
| 153 | metanephric epithelium development (GO:0072207) | 2.96844334 |
| 154 | indole-containing compound metabolic process (GO:0042430) | 2.95776215 |
| 155 | aromatic amino acid family metabolic process (GO:0009072) | 2.94808172 |
| 156 | cellular ketone body metabolic process (GO:0046950) | 2.94628617 |
| 157 | proteasome assembly (GO:0043248) | 2.93657757 |
| 158 | cellular response to lipopolysaccharide (GO:0071222) | 2.93638585 |
| 159 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92277044 |
| 160 | oxidative phosphorylation (GO:0006119) | 2.91622706 |
| 161 | peptide biosynthetic process (GO:0043043) | 2.91204582 |
| 162 | pinocytosis (GO:0006907) | 2.90779049 |
| 163 | modified amino acid transport (GO:0072337) | 2.90184167 |
| 164 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89657481 |
| 165 | decidualization (GO:0046697) | 2.89339790 |
| 166 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.88893268 |
| 167 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.86635283 |
| 168 | response to protozoan (GO:0001562) | 2.86249342 |
| 169 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.86047438 |
| 170 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.85592004 |
| 171 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.83750389 |
| 172 | serine family amino acid biosynthetic process (GO:0009070) | 2.83424525 |
| 173 | vitamin transport (GO:0051180) | 2.82783580 |
| 174 | response to insecticide (GO:0017085) | 2.82613614 |
| 175 | cellular response to molecule of bacterial origin (GO:0071219) | 2.81335674 |
| 176 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81122059 |
| 177 | positive regulation of interleukin-6 production (GO:0032755) | 2.79975544 |
| 178 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79874285 |
| 179 | glucosamine-containing compound catabolic process (GO:1901072) | 2.79293253 |
| 180 | bicarbonate transport (GO:0015701) | 2.77787255 |
| 181 | regulation of immunoglobulin secretion (GO:0051023) | 2.74828650 |
| 182 | skeletal muscle contraction (GO:0003009) | 2.74604573 |
| 183 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.74504077 |
| 184 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73941882 |
| 185 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72826521 |
| 186 | positive regulation of interferon-alpha production (GO:0032727) | 2.71194397 |
| 187 | positive regulation of type 2 immune response (GO:0002830) | 2.71193550 |
| 188 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.67153453 |
| 189 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.65374342 |
| 190 | defense response to protozoan (GO:0042832) | 2.63843009 |
| 191 | positive regulation of prostaglandin secretion (GO:0032308) | 2.63482481 |
| 192 | positive regulation of bone resorption (GO:0045780) | 2.63302036 |
| 193 | positive regulation of bone remodeling (GO:0046852) | 2.63302036 |
| 194 | regulation of prostaglandin secretion (GO:0032306) | 2.63292488 |
| 195 | regulation of response to interferon-gamma (GO:0060330) | 2.61137324 |
| 196 | positive regulation of humoral immune response (GO:0002922) | 2.60948089 |
| 197 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 13.2457639 |
| 198 | protoporphyrinogen IX metabolic process (GO:0046501) | 12.7490218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32931219 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.42960949 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.38590947 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.35406166 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.94859452 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72287268 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.49270279 |
| 8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47718817 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20576977 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.15065853 |
| 11 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.08243693 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.08243693 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.08243693 |
| 14 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.99588672 |
| 15 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.99492063 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.98864752 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96152524 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.94304636 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87412692 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.75153229 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.71400198 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.67259661 |
| 23 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.54568752 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51515609 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.49780573 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46333333 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.45481370 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.43108805 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.42389449 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.41320984 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.37521887 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.35786945 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.28285064 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26601514 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25340106 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.21036114 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18884791 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14297398 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.13709512 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.11809255 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.10331278 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.07918326 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.07611607 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04826686 |
| 45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.03278059 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 2.01012612 |
| 47 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.00738111 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99200982 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.91931569 |
| 50 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89282105 |
| 51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84736345 |
| 52 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82260298 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.79108289 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78684927 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76349882 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73132427 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72243537 |
| 58 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.69030301 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.68319537 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.67239601 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66024433 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65008961 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63606347 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63162320 |
| 65 | GATA2_19941826_ChIP-Seq_K562_Human | 1.63029986 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.61540377 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61279611 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59645326 |
| 69 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.56700643 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56159379 |
| 71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56025343 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52967109 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49928239 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49564765 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48541887 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46324053 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45134590 |
| 78 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.44133914 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40178632 |
| 80 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.39314282 |
| 81 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.38922239 |
| 82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38054972 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37115595 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36238443 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35615880 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35555119 |
| 87 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35188051 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35186399 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34855957 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33947040 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33595538 |
| 92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33466307 |
| 93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33133684 |
| 94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33119711 |
| 95 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.32723451 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32061406 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31040204 |
| 98 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30620679 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30528066 |
| 100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29765593 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29001869 |
| 102 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26179932 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25180075 |
| 104 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25076989 |
| 105 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24786834 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21071170 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20894713 |
| 108 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20397438 |
| 109 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19954493 |
| 110 | MAF_26560356_Chip-Seq_TH1_Human | 1.19504554 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18189123 |
| 112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17794344 |
| 113 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16903947 |
| 114 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16579260 |
| 115 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14465208 |
| 116 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13490021 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13479918 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.13468059 |
| 119 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13300879 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12932933 |
| 121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12587536 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11251286 |
| 123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10834510 |
| 124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10524058 |
| 125 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09836347 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08934482 |
| 127 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08503617 |
| 128 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.08134602 |
| 129 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07373437 |
| 130 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.06874015 |
| 131 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06710804 |
| 132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05840105 |
| 133 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04296133 |
| 134 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03063481 |
| 135 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02662089 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02595792 |
| 137 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.02143561 |
| 138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.99116138 |
| 139 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.98886019 |
| 140 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97470814 |
| 141 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97110946 |
| 142 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96711178 |
| 143 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96492708 |
| 144 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96422074 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.95667553 |
| 146 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95432032 |
| 147 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.93411413 |
| 148 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93406601 |
| 149 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93406601 |
| 150 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93074945 |
| 151 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92606069 |
| 152 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91908077 |
| 153 | * GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.91865550 |
| 154 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.91326096 |
| 155 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.89875472 |
| 156 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89185721 |
| 157 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89063900 |
| 158 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87818002 |
| 159 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.87085866 |
| 160 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86832900 |
| 161 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86614084 |
| 162 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85338442 |
| 163 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85173969 |
| 164 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.85052575 |
| 165 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.84711662 |
| 166 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83614483 |
| 167 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.83288263 |
| 168 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83080692 |
| 169 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.83006415 |
| 170 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81574216 |
| 171 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.81389194 |
| 172 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80641972 |
| 173 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.80633315 |
| 174 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80552491 |
| 175 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80432066 |
| 176 | MYC_22102868_ChIP-Seq_BL_Human | 0.80185366 |
| 177 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80153380 |
| 178 | UTX_26944678_Chip-Seq_JUKART_Human | 0.78883016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 9.27119510 |
| 2 | MP0005360_urolithiasis | 5.69048942 |
| 3 | MP0003303_peritoneal_inflammation | 5.05896158 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 4.51486337 |
| 5 | MP0004043_abnormal_pH_regulation | 4.50701177 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.85662220 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.83169968 |
| 8 | MP0006082_CNS_inflammation | 3.78640078 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.73417181 |
| 10 | MP0002254_reproductive_system_inflammat | 3.62990359 |
| 11 | MP0004510_myositis | 3.62449222 |
| 12 | MP0003195_calcinosis | 3.57854097 |
| 13 | MP0005636_abnormal_mineral_homeostasis | 3.37364007 |
| 14 | MP0005332_abnormal_amino_acid | 3.24008532 |
| 15 | MP0009840_abnormal_foam_cell | 3.21655254 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.99154194 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.98168310 |
| 18 | MP0003436_decreased_susceptibility_to | 2.72871994 |
| 19 | MP0009643_abnormal_urine_homeostasis | 2.66690887 |
| 20 | MP0009278_abnormal_bone_marrow | 2.64165452 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.63558635 |
| 22 | MP0009785_altered_susceptibility_to | 2.56236937 |
| 23 | MP0000604_amyloidosis | 2.42655815 |
| 24 | MP0003136_yellow_coat_color | 2.41925679 |
| 25 | MP0003186_abnormal_redox_activity | 2.37876028 |
| 26 | MP0002419_abnormal_innate_immunity | 2.21883573 |
| 27 | MP0001764_abnormal_homeostasis | 2.21654434 |
| 28 | MP0008004_abnormal_stomach_pH | 2.18358904 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 2.14331207 |
| 30 | MP0003172_abnormal_lysosome_physiology | 2.13261956 |
| 31 | MP0005671_abnormal_response_to | 2.11214611 |
| 32 | MP0001765_abnormal_ion_homeostasis | 2.08725036 |
| 33 | MP0003075_altered_response_to | 2.07662346 |
| 34 | MP0000343_altered_response_to | 2.05849923 |
| 35 | MP0001853_heart_inflammation | 2.05356867 |
| 36 | MP0005000_abnormal_immune_tolerance | 2.04709943 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.97833001 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.97730621 |
| 39 | MP0001756_abnormal_urination | 1.94320704 |
| 40 | MP0005025_abnormal_response_to | 1.91833096 |
| 41 | MP0001790_abnormal_immune_system | 1.90911923 |
| 42 | MP0005387_immune_system_phenotype | 1.90911923 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.89792603 |
| 44 | MP0002136_abnormal_kidney_physiology | 1.88831802 |
| 45 | MP0005365_abnormal_bile_salt | 1.87938809 |
| 46 | MP0003690_abnormal_glial_cell | 1.82996927 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.82342649 |
| 48 | MP0003252_abnormal_bile_duct | 1.81222204 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.78268012 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.76608239 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.75105485 |
| 52 | MP0004947_skin_inflammation | 1.73770899 |
| 53 | MP0002132_abnormal_respiratory_system | 1.71330946 |
| 54 | MP0005451_abnormal_body_composition | 1.71039856 |
| 55 | MP0000566_synostosis | 1.68315847 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 1.68115055 |
| 57 | MP0003878_abnormal_ear_physiology | 1.68115055 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.66211487 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.62515110 |
| 60 | MP0001188_hyperpigmentation | 1.61187410 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.56011262 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55926810 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.52738123 |
| 64 | MP0002723_abnormal_immune_serum | 1.50029646 |
| 65 | MP0000749_muscle_degeneration | 1.48068246 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.42643759 |
| 67 | MP0005647_abnormal_sex_gland | 1.37443601 |
| 68 | MP0003448_altered_tumor_morphology | 1.36614386 |
| 69 | MP0003941_abnormal_skin_development | 1.35835799 |
| 70 | MP0005166_decreased_susceptibility_to | 1.30874154 |
| 71 | MP0001800_abnormal_humoral_immune | 1.28701892 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.28245911 |
| 73 | MP0003329_amyloid_beta_deposits | 1.25558502 |
| 74 | MP0009697_abnormal_copulation | 1.23489894 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.22183606 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.20178522 |
| 77 | MP0001819_abnormal_immune_cell | 1.17483082 |
| 78 | MP0002420_abnormal_adaptive_immunity | 1.16213711 |
| 79 | MP0005408_hypopigmentation | 1.13771509 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 1.12862882 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.12131382 |
| 82 | MP0005310_abnormal_salivary_gland | 1.11586485 |
| 83 | MP0000858_altered_metastatic_potential | 1.09036653 |
| 84 | MP0002405_respiratory_system_inflammati | 1.08276451 |
| 85 | MP0009379_abnormal_foot_pigmentation | 1.07184677 |
| 86 | MP0006292_abnormal_olfactory_placode | 1.05126065 |
| 87 | MP0009764_decreased_sensitivity_to | 1.01865325 |
| 88 | MP0005409_darkened_coat_color | 1.00845060 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 1.00770174 |
| 90 | MP0000538_abnormal_urinary_bladder | 0.99728884 |
| 91 | MP0000920_abnormal_myelination | 0.98745453 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.98277067 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.97046821 |
| 94 | MP0000747_muscle_weakness | 0.95315282 |
| 95 | MP0002822_catalepsy | 0.94747117 |
| 96 | MP0008872_abnormal_physiological_respon | 0.94653900 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.92766031 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.92655080 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.91993873 |
| 100 | MP0002090_abnormal_vision | 0.91239744 |
| 101 | MP0001958_emphysema | 0.90329776 |
| 102 | MP0004036_abnormal_muscle_relaxation | 0.90169165 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 0.88708955 |
| 104 | MP0005501_abnormal_skin_physiology | 0.87694676 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.87358287 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.86529436 |
| 107 | MP0006054_spinal_hemorrhage | 0.86502481 |
| 108 | MP0000490_abnormal_crypts_of | 0.85881060 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 0.85778678 |
| 110 | MP0004381_abnormal_hair_follicle | 0.84714841 |
| 111 | MP0003011_delayed_dark_adaptation | 0.83510211 |
| 112 | MP0005535_abnormal_body_temperature | 0.83504783 |
| 113 | MP0003718_maternal_effect | 0.81506061 |
| 114 | MP0002135_abnormal_kidney_morphology | 0.81496829 |
| 115 | MP0009763_increased_sensitivity_to | 0.79067953 |
| 116 | MP0001849_ear_inflammation | 0.78464530 |
| 117 | MP0003091_abnormal_cell_migration | 0.78086741 |
| 118 | MP0000751_myopathy | 0.77197391 |
| 119 | MP0001919_abnormal_reproductive_system | 0.76059465 |
| 120 | MP0003724_increased_susceptibility_to | 0.75573402 |
| 121 | MP0000716_abnormal_immune_system | 0.74968536 |
| 122 | MP0003786_premature_aging | 0.74321100 |
| 123 | MP0010307_abnormal_tumor_latency | 0.73664868 |
| 124 | MP0005390_skeleton_phenotype | 0.72819695 |
| 125 | MP0000372_irregular_coat_pigmentation | 0.72564881 |
| 126 | MP0001666_abnormal_nutrient_absorption | 0.72452028 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.72401257 |
| 128 | MP0004233_abnormal_muscle_weight | 0.72103844 |
| 129 | MP0003828_pulmonary_edema | 0.71639116 |
| 130 | MP0009053_abnormal_anal_canal | 0.70927167 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.68533868 |
| 132 | MP0005670_abnormal_white_adipose | 0.68533044 |
| 133 | MP0008469_abnormal_protein_level | 0.68160295 |
| 134 | MP0004130_abnormal_muscle_cell | 0.68087220 |
| 135 | MP0008260_abnormal_autophagy | 0.67830088 |
| 136 | MP0000685_abnormal_immune_system | 0.67782069 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.66565760 |
| 138 | MP0005266_abnormal_metabolism | 0.66105950 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.65988193 |
| 140 | MP0003879_abnormal_hair_cell | 0.65309750 |
| 141 | MP0005076_abnormal_cell_differentiation | 0.63998770 |
| 142 | MP0002928_abnormal_bile_duct | 0.63732814 |
| 143 | MP0008874_decreased_physiological_sensi | 0.63095697 |
| 144 | MP0001542_abnormal_bone_strength | 0.62570696 |
| 145 | MP0004087_abnormal_muscle_fiber | 0.61205819 |
| 146 | MP0000750_abnormal_muscle_regeneration | 0.60941425 |
| 147 | MP0005083_abnormal_biliary_tract | 0.60347299 |
| 148 | MP0010329_abnormal_lipoprotein_level | 0.60289172 |
| 149 | MP0003634_abnormal_glial_cell | 0.60171096 |
| 150 | MP0000609_abnormal_liver_physiology | 0.59986601 |
| 151 | MP0002106_abnormal_muscle_physiology | 0.59348420 |
| 152 | MP0003866_abnormal_defecation | 0.58204007 |
| 153 | MP0002877_abnormal_melanocyte_morpholog | 0.57544002 |
| 154 | MP0005330_cardiomyopathy | 0.56405306 |
| 155 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56220795 |
| 156 | MP0005165_increased_susceptibility_to | 0.56219568 |
| 157 | MP0000598_abnormal_liver_morphology | 0.55548664 |
| 158 | MP0005395_other_phenotype | 0.55314325 |
| 159 | MP0005023_abnormal_wound_healing | 0.54261601 |
| 160 | MP0001663_abnormal_digestive_system | 0.53808848 |
| 161 | MP0001545_abnormal_hematopoietic_system | 0.53781814 |
| 162 | MP0005397_hematopoietic_system_phenotyp | 0.53781814 |
| 163 | MP0005171_absent_coat_pigmentation | 0.51142235 |
| 164 | MP0002160_abnormal_reproductive_system | 0.50516763 |
| 165 | MP0003646_muscle_fatigue | 0.49471576 |
| 166 | MP0005174_abnormal_tail_pigmentation | 0.47472617 |
| 167 | MP0006035_abnormal_mitochondrial_morpho | 0.47065609 |
| 168 | MP0000689_abnormal_spleen_morphology | 0.46620679 |
| 169 | MP0004885_abnormal_endolymph | 0.45737024 |
| 170 | MP0002118_abnormal_lipid_homeostasis | 0.45344984 |
| 171 | MP0005376_homeostasis/metabolism_phenot | 0.45143719 |
| 172 | MP0009765_abnormal_xenobiotic_induced | 0.44476714 |
| 173 | MP0002938_white_spotting | 0.44323144 |
| 174 | MP0001119_abnormal_female_reproductive | 0.44277232 |
| 175 | MP0001186_pigmentation_phenotype | 0.44247222 |
| 176 | MP0002098_abnormal_vibrissa_morphology | 0.43068847 |
| 177 | MP0010386_abnormal_urinary_bladder | 0.42591840 |
| 178 | MP0008775_abnormal_heart_ventricle | 0.38300414 |
| 179 | MP0008007_abnormal_cellular_replicative | 0.37897545 |
| 180 | MP0002168_other_aberrant_phenotype | 0.36799637 |
| 181 | MP0005389_reproductive_system_phenotype | 0.36396874 |
| 182 | MP0003638_abnormal_response/metabolism_ | 0.35418677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 9.69194373 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.07980921 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.07980921 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 8.07980921 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.64505091 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.31765122 |
| 7 | Hypomagnesemia (HP:0002917) | 5.30620454 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 5.25293808 |
| 9 | Increased circulating renin level (HP:0000848) | 5.17236233 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.13790241 |
| 11 | Metabolic alkalosis (HP:0200114) | 5.13349130 |
| 12 | Disinhibition (HP:0000734) | 5.03567885 |
| 13 | Loss of speech (HP:0002371) | 5.00685406 |
| 14 | Abnormality of chloride homeostasis (HP:0011422) | 4.95692824 |
| 15 | Hypokalemic alkalosis (HP:0001949) | 4.94890150 |
| 16 | Polyuria (HP:0000103) | 4.86565202 |
| 17 | Abnormality of magnesium homeostasis (HP:0004921) | 4.81891446 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 4.76754138 |
| 19 | Abnormal urine output (HP:0012590) | 4.50374659 |
| 20 | Abnormality of macrophages (HP:0004311) | 4.44042670 |
| 21 | Proximal tubulopathy (HP:0000114) | 4.37860207 |
| 22 | Abnormality of renal excretion (HP:0011036) | 4.31379127 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.19637301 |
| 24 | Paralysis (HP:0003470) | 4.16065174 |
| 25 | Nausea (HP:0002018) | 4.11876080 |
| 26 | Gout (HP:0001997) | 4.10592933 |
| 27 | Dysostosis multiplex (HP:0000943) | 4.09055385 |
| 28 | Diaphragmatic weakness (HP:0009113) | 4.02755770 |
| 29 | Polydipsia (HP:0001959) | 3.97370013 |
| 30 | Abnormal drinking behavior (HP:0030082) | 3.97370013 |
| 31 | Mutism (HP:0002300) | 3.95960204 |
| 32 | Alkalosis (HP:0001948) | 3.91388302 |
| 33 | Neurofibrillary tangles (HP:0002185) | 3.83977876 |
| 34 | Nuclear cataract (HP:0100018) | 3.80753125 |
| 35 | Tetany (HP:0001281) | 3.71288835 |
| 36 | Ileus (HP:0002595) | 3.70981887 |
| 37 | Axonal loss (HP:0003447) | 3.66284574 |
| 38 | Generalized aminoaciduria (HP:0002909) | 3.66225547 |
| 39 | Apathy (HP:0000741) | 3.65772634 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61036394 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.59574424 |
| 42 | Hyperglycinuria (HP:0003108) | 3.57131108 |
| 43 | Abnormality of renin-angiotensin system (HP:0000847) | 3.55365411 |
| 44 | Hyperaldosteronism (HP:0000859) | 3.54482107 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 3.52685972 |
| 46 | Diminished motivation (HP:0000745) | 3.51410248 |
| 47 | Myocardial infarction (HP:0001658) | 3.46418555 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 3.42041920 |
| 49 | Poikilocytosis (HP:0004447) | 3.36228179 |
| 50 | Hyponatremia (HP:0002902) | 3.31868690 |
| 51 | Increased purine levels (HP:0004368) | 3.26907675 |
| 52 | Hyperuricemia (HP:0002149) | 3.26907675 |
| 53 | Glycosuria (HP:0003076) | 3.26396453 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 3.26396453 |
| 55 | Recurrent abscess formation (HP:0002722) | 3.18663621 |
| 56 | Stomatitis (HP:0010280) | 3.14949898 |
| 57 | Renal salt wasting (HP:0000127) | 3.14480680 |
| 58 | Agnosia (HP:0010524) | 3.12916003 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.12139176 |
| 60 | Eczematoid dermatitis (HP:0000976) | 3.08467143 |
| 61 | Optic neuritis (HP:0100653) | 3.03678179 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 3.03678179 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.03526081 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.03526081 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.03526081 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.99109536 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.96121579 |
| 68 | Renal tubular acidosis (HP:0001947) | 2.95810534 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.94861901 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.94861901 |
| 71 | Abnormality of sodium homeostasis (HP:0010931) | 2.93713999 |
| 72 | Cholelithiasis (HP:0001081) | 2.92093176 |
| 73 | Complement deficiency (HP:0004431) | 2.90510722 |
| 74 | Inappropriate behavior (HP:0000719) | 2.90446358 |
| 75 | Orchitis (HP:0100796) | 2.79719046 |
| 76 | Glomerulonephritis (HP:0000099) | 2.79378791 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.79155936 |
| 78 | Cerebral palsy (HP:0100021) | 2.75822019 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 2.74653451 |
| 80 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.72722893 |
| 81 | Abnormality of glycine metabolism (HP:0010895) | 2.72722893 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.70348217 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.67142908 |
| 84 | Hypercalciuria (HP:0002150) | 2.63984193 |
| 85 | Neuronal loss in central nervous system (HP:0002529) | 2.59655378 |
| 86 | Upper motor neuron abnormality (HP:0002127) | 2.57693385 |
| 87 | Multiple enchondromatosis (HP:0005701) | 2.56723927 |
| 88 | Metaphyseal irregularity (HP:0003025) | 2.55182601 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.53504546 |
| 90 | Hypokalemia (HP:0002900) | 2.51678389 |
| 91 | Abnormality of nucleobase metabolism (HP:0010932) | 2.51469352 |
| 92 | Nemaline bodies (HP:0003798) | 2.50152634 |
| 93 | Muscle fiber inclusion bodies (HP:0100299) | 2.49007526 |
| 94 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48959681 |
| 95 | Abnormality of renal resorption (HP:0011038) | 2.46579922 |
| 96 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.45375352 |
| 97 | Reticulocytosis (HP:0001923) | 2.44302248 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.43894959 |
| 99 | Abnormal urine phosphate concentration (HP:0012599) | 2.42856857 |
| 100 | Vomiting (HP:0002013) | 2.42545242 |
| 101 | Hypochromic anemia (HP:0001931) | 2.42188150 |
| 102 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.41124176 |
| 103 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.41099935 |
| 104 | Confusion (HP:0001289) | 2.40504318 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.39146383 |
| 106 | Renal tubular dysfunction (HP:0000124) | 2.38117753 |
| 107 | Myositis (HP:0100614) | 2.36271706 |
| 108 | Metabolic acidosis (HP:0001942) | 2.36206463 |
| 109 | Muscle fiber splitting (HP:0003555) | 2.34367066 |
| 110 | Increased serum ferritin (HP:0003281) | 2.32871904 |
| 111 | Progressive neurologic deterioration (HP:0002344) | 2.31928427 |
| 112 | Vascular calcification (HP:0004934) | 2.30470180 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 2.30397186 |
| 114 | Hepatic necrosis (HP:0002605) | 2.29278198 |
| 115 | Personality changes (HP:0000751) | 2.28088936 |
| 116 | Basal ganglia calcification (HP:0002135) | 2.26149484 |
| 117 | Enlarged kidneys (HP:0000105) | 2.26084734 |
| 118 | Microcytic anemia (HP:0001935) | 2.25321122 |
| 119 | Lethargy (HP:0001254) | 2.24894546 |
| 120 | Abnormality of reticulocytes (HP:0004312) | 2.24077418 |
| 121 | Dementia (HP:0000726) | 2.23807007 |
| 122 | Acanthocytosis (HP:0001927) | 2.23804840 |
| 123 | Exercise-induced muscle cramps (HP:0003710) | 2.23033714 |
| 124 | Amyloidosis (HP:0011034) | 2.22547797 |
| 125 | Peripheral demyelination (HP:0011096) | 2.21132154 |
| 126 | Ketoacidosis (HP:0001993) | 2.20724088 |
| 127 | Delayed CNS myelination (HP:0002188) | 2.20574556 |
| 128 | Xanthomatosis (HP:0000991) | 2.17112746 |
| 129 | Abnormality of potassium homeostasis (HP:0011042) | 2.16092202 |
| 130 | Abnormality of complement system (HP:0005339) | 2.13827110 |
| 131 | Hematochezia (HP:0002573) | 2.13058564 |
| 132 | Dicarboxylic aciduria (HP:0003215) | 2.12624460 |
| 133 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.12624460 |
| 134 | Polyneuropathy (HP:0001271) | 2.11129175 |
| 135 | Hypothermia (HP:0002045) | 2.10846654 |
| 136 | Nephrocalcinosis (HP:0000121) | 2.07893552 |
| 137 | Rickets (HP:0002748) | 2.06447176 |
| 138 | Hepatocellular necrosis (HP:0001404) | 2.06251849 |
| 139 | Keratoconjunctivitis sicca (HP:0001097) | 2.05878752 |
| 140 | Ketosis (HP:0001946) | 2.04998928 |
| 141 | Abnormal number of erythroid precursors (HP:0012131) | 2.04898023 |
| 142 | Intrahepatic cholestasis (HP:0001406) | 2.04783867 |
| 143 | Acute encephalopathy (HP:0006846) | 2.04058221 |
| 144 | Bulbar palsy (HP:0001283) | 2.02833666 |
| 145 | Abnormality of the gallbladder (HP:0005264) | 2.01305533 |
| 146 | Abnormality of the periventricular white matter (HP:0002518) | 2.01292451 |
| 147 | Renal cortical cysts (HP:0000803) | 2.01096281 |
| 148 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.00448582 |
| 149 | Hyperglycinemia (HP:0002154) | 1.97845488 |
| 150 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.96096186 |
| 151 | Purpura (HP:0000979) | 1.95802360 |
| 152 | Cerebral edema (HP:0002181) | 1.95520530 |
| 153 | Alveolar cell carcinoma (HP:0006519) | 1.95026348 |
| 154 | Poor head control (HP:0002421) | 1.94060616 |
| 155 | Abnormality of proline metabolism (HP:0010907) | 1.92832474 |
| 156 | Hydroxyprolinuria (HP:0003080) | 1.92832474 |
| 157 | Cutaneous photosensitivity (HP:0000992) | 1.92007048 |
| 158 | Cardiovascular calcification (HP:0011915) | 1.91754881 |
| 159 | Bone pain (HP:0002653) | 1.89249122 |
| 160 | Reticulocytopenia (HP:0001896) | 1.88122165 |
| 161 | 3-Methylglutaconic aciduria (HP:0003535) | 1.87615374 |
| 162 | Pathologic fracture (HP:0002756) | 1.87329850 |
| 163 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.85013685 |
| 164 | Hypophosphatemia (HP:0002148) | 1.84417741 |
| 165 | Hyperammonemia (HP:0001987) | 1.84134108 |
| 166 | Autoimmune thrombocytopenia (HP:0001973) | 1.84036741 |
| 167 | Microvesicular hepatic steatosis (HP:0001414) | 1.83821331 |
| 168 | Neoplasm of head and neck (HP:0012288) | 1.83450382 |
| 169 | Esophageal neoplasm (HP:0100751) | 1.83450382 |
| 170 | Abnormality of the basal ganglia (HP:0002134) | 1.81707673 |
| 171 | Esophageal varix (HP:0002040) | 1.79989242 |
| 172 | Exercise-induced myalgia (HP:0003738) | 1.79895120 |
| 173 | Prolonged neonatal jaundice (HP:0006579) | 1.79195491 |
| 174 | Bundle branch block (HP:0011710) | 1.79114183 |
| 175 | Protuberant abdomen (HP:0001538) | 1.78758103 |
| 176 | Widely patent fontanelles and sutures (HP:0004492) | 1.78630435 |
| 177 | Thoracic kyphosis (HP:0002942) | 1.78501118 |
| 178 | Increased IgM level (HP:0003496) | 1.77874555 |
| 179 | Memory impairment (HP:0002354) | 1.77419516 |
| 180 | Delayed epiphyseal ossification (HP:0002663) | 1.77160066 |
| 181 | Type 1 muscle fiber predominance (HP:0003803) | 1.76948582 |
| 182 | Malnutrition (HP:0004395) | 1.76826756 |
| 183 | Macrocytic anemia (HP:0001972) | 1.76249394 |
| 184 | Dysphonia (HP:0001618) | 1.76194570 |
| 185 | Keratoconjunctivitis (HP:0001096) | 1.75132234 |
| 186 | Osteomalacia (HP:0002749) | 1.74953829 |
| 187 | Abnormality of Sharpey fibers (HP:0100685) | 1.74425215 |
| 188 | Gangrene (HP:0100758) | 1.73629224 |
| 189 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69499388 |
| 190 | Abnormality of the lumbar spine (HP:0100712) | 1.69029384 |
| 191 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.68917591 |
| 192 | Pulmonary infiltrates (HP:0002113) | 1.68751776 |
| 193 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.65432886 |
| 194 | Urinary incontinence (HP:0000020) | 1.64996532 |
| 195 | Skin nodule (HP:0200036) | 1.64149465 |
| 196 | Frequent falls (HP:0002359) | 1.63658729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.95660631 |
| 2 | WNK3 | 5.00694840 |
| 3 | OXSR1 | 4.01609709 |
| 4 | RIPK1 | 3.74152509 |
| 5 | EIF2AK1 | 3.28011760 |
| 6 | TAOK2 | 3.25911928 |
| 7 | BRSK2 | 2.87626518 |
| 8 | STK16 | 2.61673909 |
| 9 | TTN | 2.47167564 |
| 10 | CLK1 | 2.46861806 |
| 11 | DDR2 | 2.45952553 |
| 12 | STK38L | 2.45760160 |
| 13 | TBK1 | 2.38957516 |
| 14 | TAOK1 | 2.28642675 |
| 15 | BCKDK | 2.21477952 |
| 16 | BUB1 | 2.20536117 |
| 17 | MAP3K11 | 2.18256806 |
| 18 | STK39 | 2.17947274 |
| 19 | CASK | 2.13673395 |
| 20 | MATK | 2.11125333 |
| 21 | MOS | 2.06331192 |
| 22 | MST4 | 1.94385858 |
| 23 | MAP3K3 | 1.90533985 |
| 24 | MAP2K3 | 1.82534178 |
| 25 | NME2 | 1.76391006 |
| 26 | BRSK1 | 1.75734389 |
| 27 | FGR | 1.74653761 |
| 28 | SRPK1 | 1.69454747 |
| 29 | MUSK | 1.67250342 |
| 30 | MAP3K14 | 1.60704449 |
| 31 | MAP3K13 | 1.60690139 |
| 32 | IRAK3 | 1.59277737 |
| 33 | VRK1 | 1.54795737 |
| 34 | TYK2 | 1.53202690 |
| 35 | MKNK2 | 1.49275369 |
| 36 | CDC42BPA | 1.48707710 |
| 37 | CSK | 1.47276403 |
| 38 | EIF2AK2 | 1.46464102 |
| 39 | PLK4 | 1.44628861 |
| 40 | LATS2 | 1.41722172 |
| 41 | MAP3K5 | 1.39273837 |
| 42 | PINK1 | 1.39180554 |
| 43 | NEK1 | 1.38994305 |
| 44 | SGK494 | 1.34651442 |
| 45 | SGK223 | 1.34651442 |
| 46 | SGK2 | 1.34186198 |
| 47 | GRK7 | 1.34100362 |
| 48 | IRAK4 | 1.33741731 |
| 49 | CAMK1D | 1.33265765 |
| 50 | MAP3K9 | 1.33228642 |
| 51 | PIM1 | 1.32898406 |
| 52 | NME1 | 1.32539806 |
| 53 | ARAF | 1.31362931 |
| 54 | MAP4K1 | 1.30487740 |
| 55 | WNK1 | 1.29628631 |
| 56 | TNIK | 1.27513017 |
| 57 | EIF2AK3 | 1.26761993 |
| 58 | CHUK | 1.19893502 |
| 59 | MARK3 | 1.14203283 |
| 60 | TIE1 | 1.13893828 |
| 61 | RIPK4 | 1.13887035 |
| 62 | TYRO3 | 1.12816351 |
| 63 | MAP3K1 | 1.09135164 |
| 64 | TXK | 1.06196845 |
| 65 | STK24 | 1.03123904 |
| 66 | ABL2 | 1.01784223 |
| 67 | MKNK1 | 1.01684112 |
| 68 | AKT3 | 0.94926689 |
| 69 | TRPM7 | 0.94739767 |
| 70 | ZAP70 | 0.92655200 |
| 71 | TGFBR2 | 0.89020624 |
| 72 | ZAK | 0.87481478 |
| 73 | DMPK | 0.84031330 |
| 74 | ADRBK2 | 0.83188348 |
| 75 | NEK9 | 0.82654595 |
| 76 | CAMKK2 | 0.80781922 |
| 77 | PAK4 | 0.79308719 |
| 78 | PRPF4B | 0.76919774 |
| 79 | DYRK3 | 0.76218860 |
| 80 | PDGFRA | 0.74148501 |
| 81 | TEC | 0.72985441 |
| 82 | STK10 | 0.72791298 |
| 83 | PLK3 | 0.72789095 |
| 84 | NEK6 | 0.71638517 |
| 85 | CDK6 | 0.71344350 |
| 86 | SGK3 | 0.71253200 |
| 87 | PKN1 | 0.68385367 |
| 88 | MAPK7 | 0.68021258 |
| 89 | BMX | 0.67537888 |
| 90 | IRAK1 | 0.67076457 |
| 91 | PBK | 0.66878703 |
| 92 | DYRK1B | 0.64535614 |
| 93 | SIK3 | 0.64033823 |
| 94 | SIK1 | 0.63491075 |
| 95 | YES1 | 0.61888817 |
| 96 | PIM2 | 0.61513304 |
| 97 | CAMK1G | 0.61412314 |
| 98 | MAPK12 | 0.58917161 |
| 99 | MAPK4 | 0.57515529 |
| 100 | AURKA | 0.56978367 |
| 101 | IKBKE | 0.55711959 |
| 102 | DAPK3 | 0.54129388 |
| 103 | TTK | 0.53640818 |
| 104 | JAK2 | 0.51117713 |
| 105 | BMPR2 | 0.49791306 |
| 106 | TESK2 | 0.49266836 |
| 107 | SGK1 | 0.46068060 |
| 108 | ICK | 0.45998431 |
| 109 | IRAK2 | 0.45607643 |
| 110 | INSRR | 0.44150145 |
| 111 | MST1R | 0.43747014 |
| 112 | PIK3CG | 0.43623046 |
| 113 | RPS6KA1 | 0.41955977 |
| 114 | PDK2 | 0.40738708 |
| 115 | EGFR | 0.40477243 |
| 116 | GRK1 | 0.39505570 |
| 117 | MAP2K7 | 0.39492065 |
| 118 | EEF2K | 0.38840849 |
| 119 | LCK | 0.38678234 |
| 120 | MAP3K8 | 0.37131379 |
| 121 | CSF1R | 0.35096873 |
| 122 | JAK1 | 0.34149671 |
| 123 | IKBKB | 0.34100404 |
| 124 | MAP2K6 | 0.33973926 |
| 125 | FGFR4 | 0.33877734 |
| 126 | MAPK11 | 0.33764986 |
| 127 | RPS6KA2 | 0.33082930 |
| 128 | MARK2 | 0.32623260 |
| 129 | ACVR1B | 0.32508230 |
| 130 | HCK | 0.32465194 |
| 131 | BLK | 0.32236792 |
| 132 | TRIB3 | 0.32154766 |
| 133 | PRKG2 | 0.30016417 |
| 134 | PDPK1 | 0.29913079 |
| 135 | PLK1 | 0.29646565 |
| 136 | PRKCD | 0.29333084 |
| 137 | BMPR1B | 0.29309762 |
| 138 | GRK5 | 0.29289142 |
| 139 | CAMK4 | 0.28565575 |
| 140 | LYN | 0.28551312 |
| 141 | CDK8 | 0.28447999 |
| 142 | BRAF | 0.28344294 |
| 143 | OBSCN | 0.28324313 |
| 144 | MYLK | 0.28156842 |
| 145 | PDK1 | 0.27892572 |
| 146 | PRKACG | 0.26996322 |
| 147 | SYK | 0.26609590 |
| 148 | CDK3 | 0.26315037 |
| 149 | AURKB | 0.26116121 |
| 150 | CSNK2A1 | 0.25829205 |
| 151 | FES | 0.24663181 |
| 152 | PRKAA2 | 0.24430265 |
| 153 | TNK2 | 0.23534461 |
| 154 | MAPKAPK2 | 0.21728023 |
| 155 | GSK3A | 0.21353059 |
| 156 | RPS6KA6 | 0.19791530 |
| 157 | PRKACA | 0.19677771 |
| 158 | STK38 | 0.19364459 |
| 159 | PRKAA1 | 0.19226362 |
| 160 | RPS6KC1 | 0.18483773 |
| 161 | RPS6KL1 | 0.18483773 |
| 162 | JAK3 | 0.18477530 |
| 163 | TLK1 | 0.18112584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 5.27534016 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.34186172 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.33123081 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.04196493 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.83750978 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.76623501 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70823796 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.67573697 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61811239 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54338273 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.51488263 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51177492 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49419770 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46655113 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.45634096 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45545191 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.38274434 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.38273981 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.34705896 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28607500 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.25338642 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.22564608 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18675281 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 2.14374372 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.12428676 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 2.11570114 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 2.03910465 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02165516 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.99034976 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.96304956 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94445960 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.93084968 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86500774 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.83602418 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.83491150 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75065551 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.73203024 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.68050531 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.61371866 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.59263922 |
| 41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.57388294 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55163318 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54560228 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50659945 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.50164635 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.49839969 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48582551 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.48392951 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48289812 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48201298 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47801779 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46697496 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 1.35141592 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33979192 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32431221 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31728779 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30794738 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30148320 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27502651 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.27079635 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27036965 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26473890 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26234576 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26041353 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25259490 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24487393 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22522403 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18359907 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14788480 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12671594 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12212830 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11580574 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10774033 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 1.09775528 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.09704239 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 1.09556997 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09125514 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08810334 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.07178736 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05239203 |
| 81 | Ribosome_Homo sapiens_hsa03010 | 1.04902441 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 1.04668890 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03367162 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03038531 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02950280 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 1.02659948 |
| 87 | DNA replication_Homo sapiens_hsa03030 | 1.01872525 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96383284 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96293203 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95869058 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95459110 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94110051 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.93527865 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.92724819 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92392544 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91308240 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90475920 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.88947593 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87991243 |
| 100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87908005 |
| 101 | Measles_Homo sapiens_hsa05162 | 0.85865992 |
| 102 | Proteasome_Homo sapiens_hsa03050 | 0.84844264 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83660225 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83350318 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80242948 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78077879 |
| 107 | RNA polymerase_Homo sapiens_hsa03020 | 0.76689459 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.76626717 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76265606 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.73657196 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69921631 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.69629918 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.67791452 |
| 114 | Purine metabolism_Homo sapiens_hsa00230 | 0.67595911 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.67103563 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66919087 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64524136 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61897817 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61135003 |
| 120 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60821798 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60746414 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59162516 |
| 123 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.56939796 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56629714 |
| 125 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54574769 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53936250 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53476625 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.52952333 |
| 129 | Base excision repair_Homo sapiens_hsa03410 | 0.52944144 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50419742 |
| 131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50310456 |
| 132 | Protein export_Homo sapiens_hsa03060 | 0.49981595 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49837075 |
| 134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49811412 |
| 135 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49787258 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46173282 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46094102 |
| 138 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45777786 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45741866 |
| 140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44430348 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42091415 |
| 142 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41964415 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40895852 |
| 144 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39843019 |
| 145 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38945981 |
| 146 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38855761 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34138984 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33747820 |
| 149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33524566 |
| 150 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32219295 |
| 151 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31953044 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31862836 |
| 153 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31623142 |
| 154 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31564432 |
| 155 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30782042 |
| 156 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30536040 |
| 157 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28365220 |
| 158 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27506060 |
| 159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27362428 |
| 160 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26869513 |
| 161 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25773052 |
| 162 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22866960 |
| 163 | RNA degradation_Homo sapiens_hsa03018 | 0.22208193 |
| 164 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19045161 |
| 165 | Mismatch repair_Homo sapiens_hsa03430 | 0.18534806 |
| 166 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18066697 |
| 167 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16673534 |
| 168 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16659282 |
| 169 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.16358412 |
| 170 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14332653 |
| 171 | Malaria_Homo sapiens_hsa05144 | 0.13957155 |
| 172 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13905309 |
| 173 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13660728 |

